Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 638.5M | 385.7M | 270.6M | 50.0M |
| Gross Profit | — | — | — | 44.8M |
| Profitability | ||||
| Operating Income | -166.8M | -280.6M | -231.8M | -179.8M |
| EBITDA | — | — | — | — |
| Net Income | -183.2M | -287.2M | -239.2M | -187.1M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 50M | 48M | 45M | 41M |
Axsome Therapeutics, Inc. Income Statement — FAQ
Axsome Therapeutics, Inc. (AXSM) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's income statement history?
The chart and table above show Axsome Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.